Works Cited

1. L. Ibáñez, S. E. Oberfield, S. Witchel, R. J. Auchus, R. J. Chang, E. Codner, P. Dabadghao, F. Darendeliler, N. S. Elbarbary, A. Gambineri, C. Garcia Rudaz, K. M. Hoeger, A. López-Bermejo, K. Ong, A. S. Peña, T. Reinehr, N. Santoro, M. Tena-Sempere, R. Tao, B. O. Yildiz, H. Alkhayyat, A. Deeb, D. Joel, R. Horikawa Zegher, and P. A. Lee, “An international consortium update: Pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence,” Hormone Research in Paediatrics, 13-Nov-2017. [Online]. Available: https://www.karger.com/Article/Fulltext/479371. [Accessed: 09-Nov-2021].

2. D Joel, “Anovulation: Signs, symptoms, causes & treatment,” Cleveland Clinic. [Online]. Available: https://my.clevelandclinic.org/health/diseases/21698-anovulation. [Accessed: 09-Nov-2021].

3. N. Dahari, L. Alaygor, and L. Heinemann, “Ovarian folliculogenesis,” Results and problems in cell differentiation. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/27300179/. [Accessed: 09-Nov-2021].

4. J. Coin, “Oligogenic syndromes associated with central obesity and insulin resistance: Models for polycystic ovary syndrome,” Polycystic Ovary Syndrome, pp. 185–200, Oct. 2002.

5. S. F. Witchel, S. E. Oberfield, and A. S. Peña, “Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls,” Journal of the Endocrine Society, vol. 3, no. 8, pp. 1545–1573, 2019.

6. R. L. Rosenfield and D. A. Ehrmann, “The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited,” Endocrine Reviews, vol. 37, no. 5, pp. 467–520, Jul. 2016, doi: 10.1210/er.2015-1104.

‌

7. Dee Unglaub Silverthorn. Human Physiology : An Integrated Approach. 8th ed., Upper Saddle River, Pearson Education, 2019.

8. J. Li, H. Chen, M. Gou, C. Tian, H. Wang, X. Song, D. L. Keefe, X. Bai, and L. Liu, “Molecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and Cumulus Cells,” Frontiers in Cell and Developmental Biology, vol. 9, 2021.

9. S. El Hayek, L. Bitar, L. H. Hamdar, F. G. Mirza, and G. Daoud, “Poly Cystic ovarian syndrome: An updated overview,” Frontiers in Physiology, vol. 7, 2016.

10. J. K. Devin, H. Nian, J. E. Celedonio, P. Wright, and N. J. Brown, “Sitagliptin decreases visceral fat and blood glucose in women with polycystic ovarian syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 105, no. 1, pp. 136–151, 2019.

11. R. K. Naz, “Polycystic ovary syndrome current status and future perspective,” Frontiers in Bioscience, vol. E6, no. 1, pp. 104–119, Jan. 2014.

12. M. J. Kłosińska and A. Kaczyńska, “Polycystic ovarian syndrome - management and treatment ,” Journal of education, health and sport, vol. 11, Sep. 2021.

13. A. Swanton, L. Storey, E. McVeigh, and T. Child, “IVF outcome in women with PCOS, PCO and normal ovarian morphology,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 149, no. 1, pp. 68–71, 2010.